Loading...
•
Sep 30, 2023
USANA Q3 2023 Earnings Report
Net sales and diluted EPS decreased due to challenging economic conditions and lower promotional activity.
Key Takeaways
USANA Health Sciences reported a decrease in net sales and diluted EPS for the third quarter of 2023, attributed to challenging economic conditions and reduced promotional activities. The company is narrowing its fiscal year 2023 net sales and diluted EPS outlook.
Third quarter net sales were $213 million, a decrease from $233 million in Q3 2022.
Third quarter diluted EPS was $0.59, compared to $0.78 in Q3 2022.
The company is finalizing plans to commence operations in India and anticipates opening this market prior to year-end.
The company generated $22 million in operating cash flow and ended the quarter with $307 million in cash and cash equivalents.
Revenue by Geographic Location
Forward Guidance
The Company is revising its net sales and earnings per share outlook for fiscal year 2023, as follows: Consolidated Net Sales $900 - $920 million and Diluted EPS $2.80 - $3.05.
Positive Outlook
- The company plans to continue to invest in and execute key strategies going forward.
- The expanding global nutrition category and consumers’ increased focus on health and wellness provide a compelling opportunity.
- The company hosted a successful Americas and Europe convention in Salt Lake City.
- Plans to commence operations in India prior to year-end.
- The company remains committed to managing costs in line with expected sales performance.
Challenges Ahead
- Inflationary pressures resulted in lower than anticipated top line performance.
- Lower promotional activity resulted in lower than anticipated top line performance.
- The strengthening of the US dollar collectively resulted in lower than anticipated top line performance
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...